/ biotech stocks
/ Market Analysis
Why Is RLMD Stock Surging Premarket? NDV-01 Trial Update and $160M PIPE Deal
Relmada Therapeutics stock surged after reporting positive Phase 2 trial results for NDV-01 and announcing a $160 million PIPE financing.
March 09, 2026
Why Is Nektar (NKTR) Stock Up 17% Premarket Today? Positive AD Trial Data
Nektar stock jumped more than 17% in premarket trading after the company reported positive 52-week data from its REZOLVE-AD atopic dermatitis trial.
February 10, 2026
Why Is RAPT Stock Skyrocketing Today? GSK’s $2.2B Offer Drives Rally
RAPT Therapeutics stock surged over 63% after GSK agreed to buy the company for $58 per share in a $2.2 billion deal.
January 20, 2026
Why Is IRWD Stock Soaring Over 30% Premarket? 2026 Revenue Outlook Beats Estimates
Ironwood Pharmaceuticals shares surged more than 30% in premarket trading after the company issued 2026 revenue guidance above Wall Street estimates.
January 02, 2026
Rezolute Shares Collapse 90% After Late-Stage Study Misses Primary Endpoint
Rezolute shares plunged 90% in premarket trading after its Phase 3 trial for ersodetug failed to show meaningful benefit in treating congenital hyperinsulinism.
December 11, 2025More from The Tokenist / biotech stocks
Why Is BIAFW Stock Surging in Premarket Trading Today?
September 26, 2025
PepGen Stock Skyrockets Over 110% on Breakthrough DM1 Trial Results
September 25, 2025
Why ATYR Shares Are Down Today: Phase 3 Trial Falls Short
September 15, 2025
Back to 
